Summit Therapeutics Inc (NAS:SMMT)
$ 18.21 -1.07 (-5.55%) Market Cap: 13.43 Bil Enterprise Value: 13.76 Bil PE Ratio: 0 PB Ratio: 30.66 GF Score: 29/100